In 2025, Eliquis, Opdivo, and Orencia were the three major drugs of BMS. The company reported a sales share of ****Â percent. Bristol-Myers Squibb is headquartered in New York City and is one of the largest pharmaceutical companies worldwide.Â
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
U.S. Securities and Exchange Commission, & Bristol-Myers Squibb. (February 11, 2026). Sales share of Bristol-Myers Squibb's three major drugs from 2021 to 2025 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 31, 2026, from /statistics/1660804/bristol-myers-squibb-s-major-three-drug-sales-share/
U.S. Securities and Exchange Commission, und Bristol-Myers Squibb. "Sales share of Bristol-Myers Squibb's three major drugs from 2021 to 2025 ." Chart. February 11, 2026. ÌÇÐÄÆƽâ°æ. Accessed July 31, 2026. /statistics/1660804/bristol-myers-squibb-s-major-three-drug-sales-share/
U.S. Securities and Exchange Commission, Bristol-Myers Squibb. (2026). Sales share of Bristol-Myers Squibb's three major drugs from 2021 to 2025 . ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 31, 2026. /statistics/1660804/bristol-myers-squibb-s-major-three-drug-sales-share/
U.S. Securities and Exchange Commission, and Bristol-Myers Squibb. "Sales Share of Bristol-myers Squibb's Three Major Drugs from 2021 to 2025 ." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 11 Feb 2026, /statistics/1660804/bristol-myers-squibb-s-major-three-drug-sales-share/
U.S. Securities and Exchange Commission & Bristol-Myers Squibb, Sales share of Bristol-Myers Squibb's three major drugs from 2021 to 2025 ÌÇÐÄÆƽâ°æ, /statistics/1660804/bristol-myers-squibb-s-major-three-drug-sales-share/ (last visited July 31, 2026)
Sales share of Bristol-Myers Squibb's three major drugs from 2021 to 2025 [Graph], U.S. Securities and Exchange Commission, & Bristol-Myers Squibb, February 11, 2026. [Online]. Available: /statistics/1660804/bristol-myers-squibb-s-major-three-drug-sales-share/
